Robert Ryu
Concepts (459)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vena Cava Filters | 19 | 2018 | 52 | 5.830 |
Why?
| Liver Neoplasms | 60 | 2014 | 546 | 4.200 |
Why?
| Embolization, Therapeutic | 41 | 2014 | 199 | 3.510 |
Why?
| Carcinoma, Hepatocellular | 41 | 2014 | 231 | 3.250 |
Why?
| Yttrium Radioisotopes | 39 | 2014 | 57 | 3.060 |
Why?
| Device Removal | 13 | 2018 | 127 | 2.980 |
Why?
| Portasystemic Shunt, Transjugular Intrahepatic | 7 | 2019 | 42 | 2.050 |
Why?
| Radiography, Interventional | 17 | 2016 | 117 | 1.880 |
Why?
| Radiology, Interventional | 5 | 2019 | 30 | 1.880 |
Why?
| Pulmonary Embolism | 9 | 2018 | 190 | 1.830 |
Why?
| Chemoembolization, Therapeutic | 21 | 2014 | 52 | 1.790 |
Why?
| Hypertension, Portal | 5 | 2016 | 121 | 1.390 |
Why?
| Radiopharmaceuticals | 18 | 2014 | 196 | 1.260 |
Why?
| Lumbar Vertebrae | 3 | 2020 | 217 | 1.250 |
Why?
| Uterine Neoplasms | 9 | 2010 | 76 | 1.210 |
Why?
| Educational Measurement | 2 | 2020 | 298 | 1.180 |
Why?
| Portal Vein | 4 | 2016 | 95 | 1.040 |
Why?
| Microspheres | 29 | 2013 | 132 | 0.990 |
Why?
| Vena Cava, Inferior | 5 | 2018 | 56 | 0.950 |
Why?
| Venous Thrombosis | 5 | 2017 | 148 | 0.940 |
Why?
| Prosthesis Design | 6 | 2017 | 293 | 0.940 |
Why?
| Practice Patterns, Physicians' | 8 | 2020 | 1267 | 0.930 |
Why?
| Treatment Outcome | 66 | 2019 | 9692 | 0.930 |
Why?
| Magnetic Resonance Imaging, Interventional | 8 | 2014 | 20 | 0.930 |
Why?
| Specialty Boards | 2 | 2020 | 43 | 0.910 |
Why?
| Total Disc Replacement | 2 | 2020 | 15 | 0.890 |
Why?
| Intervertebral Disc | 3 | 2020 | 36 | 0.870 |
Why?
| Uterus | 6 | 2007 | 197 | 0.820 |
Why?
| Venous Insufficiency | 3 | 2007 | 11 | 0.810 |
Why?
| Leiomyoma | 7 | 2007 | 46 | 0.810 |
Why?
| Saphenous Vein | 3 | 2007 | 36 | 0.790 |
Why?
| Thromboembolism | 3 | 2017 | 105 | 0.780 |
Why?
| Postoperative Complications | 5 | 2020 | 2301 | 0.740 |
Why?
| Laser Therapy | 3 | 2007 | 105 | 0.730 |
Why?
| Cerebrospinal Fluid Leak | 1 | 2020 | 28 | 0.730 |
Why?
| Prosthesis Implantation | 3 | 2017 | 148 | 0.710 |
Why?
| Intervertebral Disc Displacement | 1 | 2020 | 40 | 0.710 |
Why?
| Graft Occlusion, Vascular | 2 | 2018 | 36 | 0.670 |
Why?
| Magnetic Resonance Angiography | 10 | 2014 | 214 | 0.670 |
Why?
| Venous Thromboembolism | 4 | 2017 | 239 | 0.670 |
Why?
| Endovascular Procedures | 4 | 2020 | 290 | 0.660 |
Why?
| Middle Aged | 78 | 2019 | 28563 | 0.660 |
Why?
| Low Back Pain | 1 | 2020 | 103 | 0.650 |
Why?
| Arteriovenous Shunt, Surgical | 1 | 2018 | 16 | 0.640 |
Why?
| Cholangiopancreatography, Endoscopic Retrograde | 3 | 2019 | 187 | 0.620 |
Why?
| Ultrasonography, Interventional | 3 | 2016 | 156 | 0.620 |
Why?
| Spine | 1 | 2019 | 147 | 0.610 |
Why?
| Humans | 133 | 2020 | 122796 | 0.610 |
Why?
| Magnetic Resonance Imaging | 25 | 2015 | 3264 | 0.600 |
Why?
| Ascites | 2 | 2016 | 40 | 0.600 |
Why?
| Product Surveillance, Postmarketing | 1 | 2017 | 70 | 0.590 |
Why?
| Stents | 8 | 2015 | 491 | 0.580 |
Why?
| Aged | 60 | 2018 | 20495 | 0.580 |
Why?
| Spinal Fusion | 2 | 2019 | 226 | 0.580 |
Why?
| Orthopedic Procedures | 1 | 2019 | 221 | 0.560 |
Why?
| Tomography, X-Ray Computed | 23 | 2018 | 2500 | 0.550 |
Why?
| Time Factors | 23 | 2020 | 6682 | 0.550 |
Why?
| Esophageal and Gastric Varices | 1 | 2016 | 41 | 0.550 |
Why?
| Digestive System Neoplasms | 1 | 2015 | 7 | 0.540 |
Why?
| Brachytherapy | 8 | 2008 | 103 | 0.540 |
Why?
| Intervertebral Disc Degeneration | 1 | 2016 | 29 | 0.540 |
Why?
| Aged, 80 and over | 32 | 2018 | 6845 | 0.540 |
Why?
| Female | 93 | 2019 | 63629 | 0.530 |
Why?
| Diagnostic Imaging | 3 | 2017 | 310 | 0.510 |
Why?
| Cholestasis | 2 | 2015 | 236 | 0.500 |
Why?
| Male | 81 | 2020 | 59639 | 0.500 |
Why?
| Social Media | 1 | 2017 | 163 | 0.490 |
Why?
| Adult | 54 | 2020 | 32385 | 0.480 |
Why?
| Renal Dialysis | 1 | 2018 | 395 | 0.480 |
Why?
| Retrospective Studies | 32 | 2019 | 13433 | 0.470 |
Why?
| Clinical Competence | 2 | 2019 | 973 | 0.460 |
Why?
| Imaging, Three-Dimensional | 5 | 2011 | 511 | 0.410 |
Why?
| Liver Cirrhosis | 6 | 2019 | 252 | 0.400 |
Why?
| Angiography | 11 | 2011 | 193 | 0.400 |
Why?
| Cholangiocarcinoma | 4 | 2013 | 39 | 0.400 |
Why?
| Risk Factors | 17 | 2017 | 9381 | 0.380 |
Why?
| Uterine Artery Embolization | 1 | 2010 | 7 | 0.380 |
Why?
| Drainage | 3 | 2019 | 165 | 0.370 |
Why?
| Perfusion Imaging | 1 | 2010 | 47 | 0.370 |
Why?
| Vascular System Injuries | 3 | 2016 | 72 | 0.370 |
Why?
| Chicago | 6 | 2017 | 43 | 0.360 |
Why?
| Adenoma, Islet Cell | 1 | 2009 | 10 | 0.360 |
Why?
| Liver Abscess | 1 | 2009 | 5 | 0.360 |
Why?
| Observer Variation | 3 | 2010 | 314 | 0.350 |
Why?
| Polyvinyl Alcohol | 3 | 2005 | 14 | 0.350 |
Why?
| Thyroid Gland | 1 | 2009 | 86 | 0.350 |
Why?
| Hepatic Veins | 1 | 2008 | 35 | 0.330 |
Why?
| Contrast Media | 12 | 2016 | 387 | 0.330 |
Why?
| Phlebography | 6 | 2015 | 39 | 0.330 |
Why?
| Gelatin | 2 | 2005 | 36 | 0.330 |
Why?
| Predictive Value of Tests | 10 | 2015 | 1947 | 0.320 |
Why?
| Portography | 4 | 2016 | 13 | 0.320 |
Why?
| Databases, Factual | 7 | 2020 | 1287 | 0.320 |
Why?
| Neovascularization, Pathologic | 5 | 2009 | 292 | 0.310 |
Why?
| Pancreatic Neoplasms | 3 | 2010 | 803 | 0.310 |
Why?
| Lymphangioma, Cystic | 1 | 2007 | 4 | 0.310 |
Why?
| Referral and Consultation | 1 | 2012 | 669 | 0.310 |
Why?
| Radiation Dosage | 5 | 2016 | 156 | 0.310 |
Why?
| Bile Duct Neoplasms | 4 | 2013 | 59 | 0.310 |
Why?
| Prosthesis Failure | 3 | 2017 | 122 | 0.300 |
Why?
| Catheterization | 7 | 2013 | 165 | 0.300 |
Why?
| Angioplasty | 1 | 2007 | 41 | 0.300 |
Why?
| Aortography | 1 | 2007 | 55 | 0.300 |
Why?
| Antineoplastic Agents | 6 | 2014 | 1990 | 0.300 |
Why?
| Liver Transplantation | 5 | 2015 | 929 | 0.290 |
Why?
| Hepatic Artery | 5 | 2010 | 56 | 0.290 |
Why?
| Rabbits | 11 | 2013 | 808 | 0.290 |
Why?
| Thyroid Neoplasms | 1 | 2009 | 277 | 0.280 |
Why?
| Linear Models | 4 | 2017 | 854 | 0.280 |
Why?
| United States | 10 | 2020 | 13272 | 0.280 |
Why?
| Thrombosis | 3 | 1998 | 319 | 0.280 |
Why?
| Aortic Aneurysm, Abdominal | 1 | 2007 | 119 | 0.280 |
Why?
| Neoplasms | 4 | 2017 | 2235 | 0.280 |
Why?
| Acrylic Resins | 1 | 2005 | 41 | 0.270 |
Why?
| Blood Vessel Prosthesis Implantation | 2 | 2007 | 187 | 0.260 |
Why?
| Radiation Injuries | 5 | 2010 | 137 | 0.260 |
Why?
| Radiology | 1 | 2008 | 203 | 0.260 |
Why?
| Blister | 1 | 2004 | 45 | 0.250 |
Why?
| Ovary | 2 | 2003 | 209 | 0.250 |
Why?
| Liver Neoplasms, Experimental | 3 | 2008 | 25 | 0.250 |
Why?
| Internship and Residency | 2 | 2019 | 1065 | 0.240 |
Why?
| Arteries | 7 | 2013 | 256 | 0.240 |
Why?
| Survival Rate | 12 | 2018 | 1810 | 0.240 |
Why?
| Multivariate Analysis | 7 | 2017 | 1531 | 0.240 |
Why?
| Medicare | 2 | 2020 | 767 | 0.230 |
Why?
| Jugular Veins | 3 | 1997 | 49 | 0.220 |
Why?
| Neoplasm Staging | 8 | 2014 | 1234 | 0.220 |
Why?
| Logistic Models | 6 | 2019 | 1995 | 0.220 |
Why?
| Fluoroscopy | 2 | 2016 | 149 | 0.210 |
Why?
| Clinical Trials as Topic | 3 | 2013 | 985 | 0.210 |
Why?
| Disease Progression | 14 | 2014 | 2546 | 0.210 |
Why?
| Education, Medical, Continuing | 2 | 2017 | 140 | 0.210 |
Why?
| Neoplasms, Experimental | 2 | 2013 | 162 | 0.210 |
Why?
| Kaplan-Meier Estimate | 9 | 2015 | 884 | 0.210 |
Why?
| Constriction, Pathologic | 3 | 2019 | 212 | 0.200 |
Why?
| Liver | 7 | 2013 | 1827 | 0.200 |
Why?
| Chi-Square Distribution | 6 | 2014 | 551 | 0.200 |
Why?
| Vascular Patency | 3 | 2018 | 102 | 0.200 |
Why?
| Reoperation | 4 | 2019 | 570 | 0.200 |
Why?
| Medical Oncology | 2 | 2013 | 231 | 0.200 |
Why?
| Angiography, Digital Subtraction | 6 | 2014 | 46 | 0.200 |
Why?
| Disease Models, Animal | 6 | 2016 | 3799 | 0.200 |
Why?
| alpha-Fetoproteins | 2 | 2012 | 34 | 0.200 |
Why?
| Surgical Stomas | 1 | 2000 | 6 | 0.190 |
Why?
| Catheter Ablation | 1 | 2004 | 324 | 0.190 |
Why?
| Colostomy | 1 | 2000 | 26 | 0.190 |
Why?
| Liver Diseases | 2 | 2007 | 325 | 0.190 |
Why?
| Varicose Veins | 1 | 2000 | 15 | 0.190 |
Why?
| Infusions, Intra-Arterial | 9 | 2010 | 46 | 0.190 |
Why?
| Thrombolytic Therapy | 2 | 1998 | 122 | 0.190 |
Why?
| Sensitivity and Specificity | 9 | 2012 | 1855 | 0.190 |
Why?
| Lumbosacral Region | 1 | 2020 | 52 | 0.180 |
Why?
| Hepatorenal Syndrome | 1 | 2019 | 14 | 0.180 |
Why?
| Budd-Chiari Syndrome | 1 | 1999 | 10 | 0.180 |
Why?
| Laminoplasty | 1 | 2019 | 1 | 0.180 |
Why?
| Gastrointestinal Hemorrhage | 1 | 2000 | 113 | 0.180 |
Why?
| Image Interpretation, Computer-Assisted | 3 | 2011 | 229 | 0.170 |
Why?
| Laminectomy | 1 | 2019 | 27 | 0.170 |
Why?
| Iliac Artery | 2 | 2018 | 46 | 0.170 |
Why?
| Ohio | 1 | 2019 | 144 | 0.170 |
Why?
| Specialization | 1 | 2020 | 134 | 0.170 |
Why?
| Follow-Up Studies | 10 | 2013 | 4768 | 0.170 |
Why?
| Bile Ducts | 1 | 2019 | 74 | 0.170 |
Why?
| Glass | 3 | 2013 | 45 | 0.170 |
Why?
| Diffusion Magnetic Resonance Imaging | 2 | 2010 | 95 | 0.170 |
Why?
| Prospective Studies | 13 | 2014 | 6704 | 0.170 |
Why?
| Models, Educational | 1 | 2019 | 100 | 0.160 |
Why?
| Mesenteric Veins | 1 | 1998 | 12 | 0.160 |
Why?
| Biliary Fistula | 1 | 1998 | 3 | 0.160 |
Why?
| Survival Analysis | 6 | 2011 | 1325 | 0.160 |
Why?
| Intestine, Small | 1 | 2019 | 135 | 0.160 |
Why?
| Young Adult | 7 | 2018 | 11094 | 0.160 |
Why?
| Urinary Fistula | 1 | 1998 | 9 | 0.160 |
Why?
| Patient Selection | 5 | 2015 | 717 | 0.160 |
Why?
| Catheters | 2 | 2015 | 65 | 0.160 |
Why?
| Thrombectomy | 1 | 1998 | 61 | 0.160 |
Why?
| Writing | 1 | 2019 | 90 | 0.160 |
Why?
| Liver Circulation | 4 | 2015 | 25 | 0.150 |
Why?
| Pain | 1 | 2003 | 746 | 0.150 |
Why?
| Patient Advocacy | 1 | 2017 | 71 | 0.150 |
Why?
| Endoscopy, Gastrointestinal | 1 | 2019 | 207 | 0.150 |
Why?
| Treatment Failure | 4 | 2017 | 348 | 0.150 |
Why?
| Radiography | 7 | 2012 | 888 | 0.150 |
Why?
| Ultrasonography, Doppler, Color | 2 | 2008 | 35 | 0.140 |
Why?
| Hemostasis, Surgical | 1 | 2016 | 24 | 0.140 |
Why?
| Vena Cava, Superior | 1 | 2016 | 22 | 0.140 |
Why?
| Drug Utilization | 1 | 2017 | 183 | 0.140 |
Why?
| United States Food and Drug Administration | 1 | 2017 | 186 | 0.140 |
Why?
| History, 20th Century | 1 | 2017 | 288 | 0.140 |
Why?
| Portal Pressure | 1 | 2016 | 7 | 0.140 |
Why?
| Cell Line, Tumor | 7 | 2013 | 2904 | 0.140 |
Why?
| Doxorubicin | 3 | 2013 | 304 | 0.140 |
Why?
| Academic Medical Centers | 1 | 2019 | 427 | 0.140 |
Why?
| Lower Extremity | 1 | 2020 | 345 | 0.140 |
Why?
| Balloon Occlusion | 1 | 2016 | 27 | 0.140 |
Why?
| Gadolinium DTPA | 5 | 2014 | 56 | 0.140 |
Why?
| Research Design | 3 | 2013 | 1002 | 0.140 |
Why?
| Anatomic Landmarks | 1 | 2016 | 28 | 0.140 |
Why?
| Finite Element Analysis | 1 | 2016 | 71 | 0.140 |
Why?
| Operative Time | 1 | 2016 | 117 | 0.140 |
Why?
| Reproducibility of Results | 8 | 2011 | 2977 | 0.140 |
Why?
| Aorta | 1 | 2018 | 368 | 0.130 |
Why?
| Stomach | 2 | 2013 | 109 | 0.130 |
Why?
| Radiation Exposure | 1 | 2016 | 52 | 0.130 |
Why?
| Models, Anatomic | 1 | 2016 | 94 | 0.130 |
Why?
| Adolescent | 14 | 2018 | 18948 | 0.130 |
Why?
| Bile Ducts, Intrahepatic | 3 | 2013 | 54 | 0.130 |
Why?
| Intraoperative Complications | 1 | 2016 | 132 | 0.130 |
Why?
| Cisplatin | 3 | 2012 | 269 | 0.130 |
Why?
| Wounds, Nonpenetrating | 4 | 2000 | 290 | 0.130 |
Why?
| Sex Factors | 2 | 2018 | 1860 | 0.130 |
Why?
| Dilatation | 1 | 2015 | 57 | 0.130 |
Why?
| Hospital Mortality | 2 | 2018 | 901 | 0.130 |
Why?
| Length of Stay | 2 | 2019 | 1077 | 0.130 |
Why?
| Wounds, Gunshot | 1 | 1998 | 178 | 0.130 |
Why?
| Education, Medical, Graduate | 1 | 2019 | 432 | 0.130 |
Why?
| Carotid Artery Injuries | 3 | 2000 | 42 | 0.130 |
Why?
| Biopsy | 3 | 2014 | 1090 | 0.120 |
Why?
| Data Interpretation, Statistical | 3 | 2013 | 345 | 0.120 |
Why?
| End Stage Liver Disease | 1 | 2015 | 81 | 0.120 |
Why?
| Foreign-Body Migration | 1 | 2014 | 39 | 0.120 |
Why?
| Stress, Mechanical | 1 | 2016 | 440 | 0.120 |
Why?
| Carbon Dioxide | 1 | 2016 | 237 | 0.120 |
Why?
| Peripheral Arterial Disease | 1 | 2020 | 398 | 0.120 |
Why?
| Anticoagulants | 2 | 2017 | 589 | 0.120 |
Why?
| Magnetite Nanoparticles | 1 | 2013 | 28 | 0.120 |
Why?
| Duodenum | 1 | 2013 | 65 | 0.120 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2014 | 1402 | 0.120 |
Why?
| Kidney Diseases | 1 | 1998 | 446 | 0.120 |
Why?
| Arthroscopy | 3 | 1992 | 233 | 0.110 |
Why?
| Biomechanical Phenomena | 1 | 2016 | 705 | 0.110 |
Why?
| Catheterization, Peripheral | 3 | 2008 | 110 | 0.110 |
Why?
| Patient Education as Topic | 1 | 2017 | 717 | 0.110 |
Why?
| Proportional Hazards Models | 5 | 2014 | 1184 | 0.110 |
Why?
| Acromion | 1 | 1992 | 10 | 0.110 |
Why?
| Fibrin | 1 | 2012 | 63 | 0.110 |
Why?
| Shoulder Injuries | 1 | 1992 | 62 | 0.110 |
Why?
| Electroporation | 1 | 2012 | 33 | 0.100 |
Why?
| Fibromuscular Dysplasia | 1 | 2011 | 4 | 0.100 |
Why?
| Respiratory-Gated Imaging Techniques | 1 | 2011 | 8 | 0.100 |
Why?
| Rotator Cuff | 1 | 1992 | 50 | 0.100 |
Why?
| Tendon Injuries | 1 | 1992 | 81 | 0.100 |
Why?
| Prognosis | 5 | 2010 | 3563 | 0.100 |
Why?
| Comorbidity | 1 | 2016 | 1600 | 0.100 |
Why?
| Yttrium | 1 | 2010 | 5 | 0.100 |
Why?
| Neuroendocrine Tumors | 1 | 2011 | 91 | 0.100 |
Why?
| Injections, Intra-Arterial | 5 | 2012 | 25 | 0.090 |
Why?
| Biomarkers, Tumor | 3 | 2012 | 1076 | 0.090 |
Why?
| Surgery, Computer-Assisted | 1 | 2011 | 71 | 0.090 |
Why?
| Research Report | 1 | 2011 | 83 | 0.090 |
Why?
| Punctures | 1 | 2010 | 39 | 0.090 |
Why?
| Decision Support Techniques | 1 | 2014 | 392 | 0.090 |
Why?
| Gastrostomy | 2 | 2009 | 93 | 0.090 |
Why?
| Biopsy, Fine-Needle | 1 | 2009 | 71 | 0.090 |
Why?
| Pancreatic Pseudocyst | 1 | 2009 | 14 | 0.090 |
Why?
| Palliative Care | 1 | 2015 | 632 | 0.090 |
Why?
| Breast Neoplasms | 2 | 2014 | 1994 | 0.090 |
Why?
| Bilirubin | 3 | 2010 | 95 | 0.090 |
Why?
| Necrosis | 4 | 2010 | 238 | 0.080 |
Why?
| Practice Guidelines as Topic | 4 | 2013 | 1519 | 0.080 |
Why?
| Radiation Pneumonitis | 1 | 2008 | 26 | 0.080 |
Why?
| Prevalence | 2 | 2012 | 2442 | 0.080 |
Why?
| Cohort Studies | 4 | 2018 | 5294 | 0.080 |
Why?
| Liver Function Tests | 3 | 2015 | 114 | 0.080 |
Why?
| Ambulatory Care Facilities | 1 | 2010 | 244 | 0.080 |
Why?
| Biliary Tract | 1 | 2008 | 17 | 0.080 |
Why?
| Radiotherapy Dosage | 4 | 2010 | 244 | 0.080 |
Why?
| Maximum Allowable Concentration | 1 | 2007 | 14 | 0.080 |
Why?
| Knee Injuries | 1 | 1989 | 106 | 0.080 |
Why?
| Animals | 13 | 2016 | 34133 | 0.080 |
Why?
| Subtraction Technique | 1 | 2007 | 29 | 0.080 |
Why?
| Endpoint Determination | 3 | 2013 | 69 | 0.080 |
Why?
| Neoplasm Transplantation | 1 | 2008 | 248 | 0.080 |
Why?
| Diagnosis, Differential | 3 | 2009 | 1423 | 0.080 |
Why?
| Vacuum Curettage | 1 | 2007 | 5 | 0.080 |
Why?
| Diagnostic Errors | 1 | 2008 | 171 | 0.080 |
Why?
| Incidence | 3 | 2009 | 2527 | 0.080 |
Why?
| Catheterization, Central Venous | 2 | 1999 | 95 | 0.070 |
Why?
| Leiomyomatosis | 1 | 2006 | 1 | 0.070 |
Why?
| Credentialing | 1 | 2006 | 12 | 0.070 |
Why?
| Image Enhancement | 4 | 2011 | 185 | 0.070 |
Why?
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2008 | 252 | 0.070 |
Why?
| Iron | 1 | 2008 | 239 | 0.070 |
Why?
| Radiotherapy | 1 | 2008 | 187 | 0.070 |
Why?
| Ultrasonography | 2 | 2015 | 740 | 0.070 |
Why?
| Knee Joint | 1 | 1989 | 366 | 0.070 |
Why?
| Quality Assurance, Health Care | 1 | 2008 | 362 | 0.070 |
Why?
| Ethics, Research | 1 | 2005 | 35 | 0.070 |
Why?
| Fluorescent Dyes | 1 | 2007 | 319 | 0.070 |
Why?
| Personnel Selection | 1 | 2006 | 77 | 0.070 |
Why?
| Regional Blood Flow | 2 | 2007 | 427 | 0.070 |
Why?
| Decision Making | 1 | 2012 | 840 | 0.070 |
Why?
| Organ Size | 3 | 2013 | 474 | 0.070 |
Why?
| Kidney Transplantation | 1 | 2011 | 584 | 0.060 |
Why?
| Heart Failure | 1 | 2018 | 2114 | 0.060 |
Why?
| Postmenopause | 1 | 2007 | 307 | 0.060 |
Why?
| Ultrasonography, Doppler, Duplex | 1 | 2004 | 39 | 0.060 |
Why?
| Combined Modality Therapy | 2 | 2017 | 1174 | 0.060 |
Why?
| Pilot Projects | 4 | 2009 | 1477 | 0.060 |
Why?
| Odds Ratio | 2 | 2017 | 1043 | 0.060 |
Why?
| Dose-Response Relationship, Radiation | 3 | 2008 | 131 | 0.060 |
Why?
| Analgesia, Patient-Controlled | 1 | 2003 | 10 | 0.060 |
Why?
| Fellowships and Scholarships | 1 | 2006 | 255 | 0.060 |
Why?
| Ischemia | 1 | 2006 | 382 | 0.060 |
Why?
| Illinois | 3 | 2009 | 39 | 0.060 |
Why?
| Menisci, Tibial | 2 | 1995 | 59 | 0.050 |
Why?
| Hepatectomy | 2 | 2013 | 146 | 0.050 |
Why?
| Aneurysm, False | 2 | 2000 | 48 | 0.050 |
Why?
| Feasibility Studies | 3 | 2011 | 780 | 0.050 |
Why?
| Colorectal Neoplasms | 1 | 2009 | 646 | 0.050 |
Why?
| Drug Stability | 2 | 2013 | 157 | 0.050 |
Why?
| Tumor Burden | 2 | 2014 | 277 | 0.050 |
Why?
| Confidence Intervals | 2 | 2013 | 339 | 0.050 |
Why?
| World Health Organization | 2 | 2012 | 115 | 0.050 |
Why?
| Recurrence | 2 | 2000 | 998 | 0.050 |
Why?
| Europe | 2 | 2012 | 369 | 0.050 |
Why?
| Administrative Claims, Healthcare | 1 | 2020 | 24 | 0.050 |
Why?
| Carotid Artery, Internal | 1 | 2000 | 34 | 0.050 |
Why?
| Radiologists | 1 | 2020 | 39 | 0.050 |
Why?
| Cardiologists | 1 | 2020 | 41 | 0.050 |
Why?
| Disease-Free Survival | 2 | 2013 | 661 | 0.040 |
Why?
| Ambulatory Surgical Procedures | 1 | 2020 | 53 | 0.040 |
Why?
| Menstrual Cycle | 1 | 2000 | 115 | 0.040 |
Why?
| Hepatic Encephalopathy | 1 | 1999 | 22 | 0.040 |
Why?
| Hospitalization | 2 | 2020 | 1914 | 0.040 |
Why?
| Tomography, Emission-Computed | 2 | 2009 | 59 | 0.040 |
Why?
| Tracheoesophageal Fistula | 1 | 1999 | 33 | 0.040 |
Why?
| Anastomosis, Surgical | 1 | 2019 | 151 | 0.040 |
Why?
| Evidence-Based Medicine | 2 | 2013 | 731 | 0.040 |
Why?
| Liver Failure | 1 | 1999 | 94 | 0.040 |
Why?
| Streptokinase | 1 | 1998 | 11 | 0.040 |
Why?
| Serum Albumin | 1 | 1999 | 151 | 0.040 |
Why?
| Ethiodized Oil | 2 | 2008 | 6 | 0.040 |
Why?
| Postoperative Hemorrhage | 1 | 1999 | 89 | 0.040 |
Why?
| Equipment Design | 2 | 2012 | 533 | 0.040 |
Why?
| Mitomycin | 2 | 2008 | 27 | 0.040 |
Why?
| Multiple Organ Failure | 1 | 1999 | 166 | 0.040 |
Why?
| Analysis of Variance | 2 | 2011 | 1329 | 0.040 |
Why?
| Swine | 2 | 2016 | 777 | 0.040 |
Why?
| Guidelines as Topic | 2 | 2010 | 273 | 0.040 |
Why?
| Nervous System Diseases | 2 | 2017 | 265 | 0.040 |
Why?
| Cause of Death | 1 | 1999 | 389 | 0.040 |
Why?
| Cartilage Diseases | 2 | 1995 | 49 | 0.040 |
Why?
| Intracranial Hypertension | 1 | 1997 | 41 | 0.040 |
Why?
| AIDS-Related Opportunistic Infections | 1 | 1997 | 114 | 0.040 |
Why?
| Radiography, Thoracic | 1 | 1997 | 168 | 0.040 |
Why?
| Abdominal Injuries | 1 | 1998 | 122 | 0.040 |
Why?
| Tuberculosis, Pulmonary | 1 | 1997 | 127 | 0.040 |
Why?
| Demography | 1 | 2017 | 290 | 0.040 |
Why?
| Acute Disease | 1 | 1999 | 984 | 0.040 |
Why?
| Recovery of Function | 1 | 2000 | 610 | 0.040 |
Why?
| Databases as Topic | 2 | 2010 | 79 | 0.030 |
Why?
| Positron-Emission Tomography | 2 | 2008 | 308 | 0.030 |
Why?
| Ambulatory Care | 1 | 2020 | 497 | 0.030 |
Why?
| Surgeons | 1 | 2020 | 245 | 0.030 |
Why?
| Inpatients | 1 | 2019 | 402 | 0.030 |
Why?
| Case-Control Studies | 1 | 2003 | 3296 | 0.030 |
Why?
| Fibrinolytic Agents | 1 | 1998 | 257 | 0.030 |
Why?
| Lung | 1 | 2008 | 3830 | 0.030 |
Why?
| Models, Cardiovascular | 1 | 2016 | 183 | 0.030 |
Why?
| Phantoms, Imaging | 2 | 2008 | 154 | 0.030 |
Why?
| Cysts | 1 | 1995 | 94 | 0.030 |
Why?
| Embolism | 2 | 2008 | 45 | 0.030 |
Why?
| Hospitals, Pediatric | 1 | 2017 | 507 | 0.030 |
Why?
| Preoperative Care | 1 | 2016 | 342 | 0.030 |
Why?
| Ablation Techniques | 1 | 2013 | 29 | 0.030 |
Why?
| Vascular Surgical Procedures | 1 | 2016 | 277 | 0.030 |
Why?
| Eligibility Determination | 1 | 2013 | 60 | 0.030 |
Why?
| Scapula | 1 | 1992 | 45 | 0.030 |
Why?
| Radiotherapy, Adjuvant | 1 | 2013 | 191 | 0.030 |
Why?
| Biomarkers | 2 | 2014 | 3662 | 0.030 |
Why?
| Nausea | 1 | 2011 | 110 | 0.030 |
Why?
| Muscular Diseases | 1 | 1992 | 108 | 0.020 |
Why?
| Vomiting | 1 | 2011 | 126 | 0.020 |
Why?
| International Agencies | 1 | 2010 | 29 | 0.020 |
Why?
| Clinical Trials, Phase II as Topic | 1 | 2010 | 58 | 0.020 |
Why?
| Neoadjuvant Therapy | 1 | 2013 | 348 | 0.020 |
Why?
| Diarrhea | 1 | 2011 | 181 | 0.020 |
Why?
| Abdominal Pain | 1 | 2011 | 141 | 0.020 |
Why?
| Standard of Care | 1 | 2010 | 67 | 0.020 |
Why?
| Yttrium Isotopes | 1 | 2009 | 1 | 0.020 |
Why?
| Risk Assessment | 2 | 2009 | 3213 | 0.020 |
Why?
| Fatigue | 1 | 2011 | 311 | 0.020 |
Why?
| Leukocyte Count | 1 | 2010 | 309 | 0.020 |
Why?
| Registries | 1 | 2018 | 2020 | 0.020 |
Why?
| Alkaline Phosphatase | 1 | 2010 | 161 | 0.020 |
Why?
| Terminology as Topic | 1 | 2011 | 217 | 0.020 |
Why?
| Chronic Disease | 1 | 2015 | 1645 | 0.020 |
Why?
| Range of Motion, Articular | 1 | 1992 | 385 | 0.020 |
Why?
| Age Factors | 1 | 2017 | 3114 | 0.020 |
Why?
| Fibula | 1 | 1989 | 37 | 0.020 |
Why?
| Ligaments, Articular | 1 | 1989 | 57 | 0.020 |
Why?
| ROC Curve | 1 | 2010 | 494 | 0.020 |
Why?
| Rhenium | 1 | 2008 | 9 | 0.020 |
Why?
| Radioisotopes | 1 | 2008 | 36 | 0.020 |
Why?
| Iohexol | 1 | 2008 | 21 | 0.020 |
Why?
| Body Burden | 1 | 2007 | 5 | 0.020 |
Why?
| Hysterosalpingography | 1 | 2007 | 6 | 0.020 |
Why?
| Femur | 1 | 1989 | 201 | 0.020 |
Why?
| Tissue Distribution | 1 | 2008 | 339 | 0.020 |
Why?
| Rats, Sprague-Dawley | 1 | 2013 | 2501 | 0.020 |
Why?
| Tibia | 1 | 1989 | 182 | 0.020 |
Why?
| Hindlimb | 1 | 2008 | 138 | 0.020 |
Why?
| Celiac Artery | 1 | 2007 | 14 | 0.020 |
Why?
| Injections | 1 | 2008 | 171 | 0.020 |
Why?
| Mesenteric Arteries | 1 | 2007 | 16 | 0.020 |
Why?
| Regression Analysis | 1 | 2010 | 1018 | 0.020 |
Why?
| Equipment Failure Analysis | 1 | 2007 | 142 | 0.020 |
Why?
| Contraindications | 1 | 2007 | 102 | 0.020 |
Why?
| Weight Loss | 1 | 2011 | 663 | 0.020 |
Why?
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2007 | 112 | 0.020 |
Why?
| Injury Severity Score | 2 | 2000 | 541 | 0.020 |
Why?
| Tumor Cells, Cultured | 1 | 2008 | 904 | 0.020 |
Why?
| Retreatment | 1 | 2005 | 72 | 0.020 |
Why?
| Cartilage, Articular | 1 | 1989 | 315 | 0.020 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2010 | 1260 | 0.020 |
Why?
| Rats | 1 | 2013 | 5426 | 0.020 |
Why?
| Neoplasm Metastasis | 1 | 2007 | 563 | 0.020 |
Why?
| Algorithms | 1 | 2011 | 1593 | 0.010 |
Why?
| Child, Preschool | 1 | 2017 | 9755 | 0.010 |
Why?
| Child | 3 | 2017 | 19561 | 0.010 |
Why?
| Blood Flow Velocity | 1 | 2002 | 333 | 0.010 |
Why?
| Aorta, Abdominal | 1 | 2000 | 43 | 0.010 |
Why?
| Models, Animal | 1 | 2002 | 373 | 0.010 |
Why?
| Arteriosclerosis | 1 | 2000 | 90 | 0.010 |
Why?
| Pneumonia, Aspiration | 1 | 1999 | 16 | 0.010 |
Why?
| Hematoma | 1 | 1999 | 54 | 0.010 |
Why?
| Veins | 1 | 1999 | 63 | 0.010 |
Why?
| Esophageal Stenosis | 1 | 1999 | 47 | 0.010 |
Why?
| Intubation, Gastrointestinal | 1 | 1999 | 61 | 0.010 |
Why?
| Aortic Diseases | 1 | 2000 | 95 | 0.010 |
Why?
| Decision Trees | 1 | 1998 | 95 | 0.010 |
Why?
| Arm | 1 | 1999 | 107 | 0.010 |
Why?
| Peripheral Nervous System Diseases | 1 | 1999 | 126 | 0.010 |
Why?
| Cerebral Infarction | 1 | 1997 | 45 | 0.010 |
Why?
| Polymorphism, Restriction Fragment Length | 1 | 1997 | 64 | 0.010 |
Why?
| Los Angeles | 1 | 1997 | 61 | 0.010 |
Why?
| Carotid Artery Diseases | 1 | 1997 | 61 | 0.010 |
Why?
| Neurologic Examination | 1 | 1997 | 127 | 0.010 |
Why?
| Enteral Nutrition | 1 | 1999 | 174 | 0.010 |
Why?
| Intracranial Pressure | 1 | 1997 | 54 | 0.010 |
Why?
| Glasgow Coma Scale | 1 | 1997 | 160 | 0.010 |
Why?
| Clinical Protocols | 1 | 1998 | 248 | 0.010 |
Why?
| Multiple Trauma | 1 | 1997 | 98 | 0.010 |
Why?
| Carotid Stenosis | 1 | 1997 | 80 | 0.010 |
Why?
| Angioplasty, Balloon | 1 | 1997 | 92 | 0.010 |
Why?
| Carotid Arteries | 1 | 1997 | 189 | 0.010 |
Why?
| Heparin | 1 | 1997 | 240 | 0.010 |
Why?
| HIV | 1 | 1997 | 219 | 0.010 |
Why?
| DNA, Bacterial | 1 | 1997 | 324 | 0.010 |
Why?
| Craniocerebral Trauma | 1 | 1997 | 154 | 0.010 |
Why?
| Cluster Analysis | 1 | 1997 | 493 | 0.010 |
Why?
| Synovial Cyst | 1 | 1995 | 2 | 0.010 |
Why?
| DNA, Viral | 1 | 1997 | 358 | 0.010 |
Why?
| Mycobacterium tuberculosis | 1 | 1997 | 304 | 0.010 |
Why?
| Brain Ischemia | 1 | 1997 | 311 | 0.010 |
Why?
| Brain Injuries | 1 | 1997 | 488 | 0.010 |
Why?
| Tibial Meniscus Injuries | 1 | 1990 | 46 | 0.010 |
Why?
| Postoperative Period | 1 | 1990 | 317 | 0.010 |
Why?
|
|
Ryu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|